Amgen Inc.
AMGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.88 | 7.35 | 1.21 | -1.31 |
| FCF Yield | 7.37% | 4.78% | 6.22% | 6.54% |
| EV / EBITDA | 14.16 | 14.04 | 14.18 | 13.59 |
| Quality | ||||
| ROIC | 8.91% | 8.42% | 16.72% | 13.69% |
| Gross Margin | 61.53% | 70.15% | 75.66% | 75.16% |
| Cash Conversion Ratio | 2.81 | 1.26 | 1.48 | 1.57 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.29% | 2.76% | 1.17% | 3.60% |
| Free Cash Flow Growth | 41.24% | -16.23% | 4.82% | -15.25% |
| Safety | ||||
| Net Debt / EBITDA | 3.60 | 3.63 | 2.57 | 2.24 |
| Interest Coverage | 2.30 | 2.75 | 6.80 | 6.38 |
| Efficiency | ||||
| Inventory Turnover | 1.84 | 0.88 | 1.30 | 1.58 |
| Cash Conversion Cycle | 226.40 | 446.71 | 279.96 | 235.86 |